-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 FNNWmwPogV2UtOvrXvGFAl+0+5Tf9qeZHe7wJ/gVN5ZKDRYEskRj48otviBZYbwe
 h6YRp1csEexQutSwdMlB6A==

<SEC-DOCUMENT>0000919574-08-010678.txt : 20081231
<SEC-HEADER>0000919574-08-010678.hdr.sgml : 20081231
<ACCEPTANCE-DATETIME>20081231101305
ACCESSION NUMBER:		0000919574-08-010678
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20081229
FILED AS OF DATE:		20081231
DATE AS OF CHANGE:		20081231

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AUTOIMMUNE INC
		CENTRAL INDEX KEY:			0000879106
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				133489062
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		1199 MADIA STREET
		CITY:			PASADENA
		STATE:			CA
		ZIP:			91103
		BUSINESS PHONE:		6267921235

	MAIL ADDRESS:	
		STREET 1:		1199 MADIA STREET
		CITY:			PASADENA
		STATE:			CA
		ZIP:			91103

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			LUSMAN CAPITAL MANAGEMENT, LLC
		CENTRAL INDEX KEY:			0001410831

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-20948
		FILM NUMBER:		081277594

	BUSINESS ADDRESS:	
		STREET 1:		717 FIFTH AVENUE
		STREET 2:		14TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
		BUSINESS PHONE:		212-230-4790

	MAIL ADDRESS:	
		STREET 1:		717 FIFTH AVENUE
		STREET 2:		14TH FLOOR
		CITY:			NEW YORK
		STATE:			NY
		ZIP:			10022
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>p951859_ex.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0303</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2008-12-29</periodOfReport>

    <notSubjectToSection16>0</notSubjectToSection16>

    <issuer>
        <issuerCik>0000879106</issuerCik>
        <issuerName>AUTOIMMUNE INC</issuerName>
        <issuerTradingSymbol>AIMM</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001410831</rptOwnerCik>
            <rptOwnerName>LUSMAN CAPITAL MANAGEMENT, LLC</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>717 FIFTH AVENUE</rptOwnerStreet1>
            <rptOwnerStreet2>14TH FLOOR</rptOwnerStreet2>
            <rptOwnerCity>NEW YORK</rptOwnerCity>
            <rptOwnerState>NY</rptOwnerState>
            <rptOwnerZipCode>10022</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>0</isDirector>
            <isOfficer>0</isOfficer>
            <isTenPercentOwner>1</isTenPercentOwner>
            <isOther>0</isOther>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock, par value $0.01</value>
            </securityTitle>
            <transactionDate>
                <value>2008-12-29</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>P</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>41247</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>0.87</value>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>2537000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>Footnote</value>
                    <footnoteId id="F1"/>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">Mr. Lusman is the sole managing member of Lusman Capital Management, LLC and Lusman Capital GP, LLC.  In accordance with the
 foregoing, Lusman Capital Management, LLC, Lusman Capital GP, LLC and Mr. Lusman may be deemed to beneficially own the
 securities of the Issuer owned by the various entities managed by Lusman Capital Management, LLC and Lusman Capital GP, LLC
 respectively.  The Reporting Persons disclaim beneficial ownership of the reported securities except to the extent of his or
 its pecuniary interest therein, and this report shall not be deemed an admission that such reporting person is the
 beneficial owner of the securities for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any
 other purpose.</footnote>
    </footnotes>

    <remarks>(+)  The Reporting Person disclaims beneficial ownership of the reported securities except to the extent of its pecuniary
 interest therein.</remarks>

    <ownerSignature>
        <signatureName>Lusman Capital Management, LLC(+), By: /s/ Joel Lusman, Managing Member</signatureName>
        <signatureDate>2008-12-31</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----